Investments worth more than £2.7bn are being pledged today in a drive to halve the number of malaria cases across the Commonwealth. Heads of state and business leaders are convening in London to galvanise the fight against the disease, which has seen a resurgence in some areas.
As the second largest international donor, the UK has been at the forefront of efforts to reduce the number of cases for many years by investing in treatment, prevention and research, including the fight against the threat of drug resistance. The UK has announced further support for the fight against malaria to save more than 120,000 lives ahead of a Malaria Summit tomorrow with Commonwealth leaders.
Pailin, a small settlement nestling in tropical rainforest near Cambodia’s border with Thailand, lies at the heart of a region that has seen successive waves of resistance to malaria drugs arise in local people and then spread across the globe. As new waves of the disease threaten our health, worried scientists want to conduct a mass inoculation in a Cambodian region where new vaccines always seem to stop being effective.
10 April 2018 (Bangkok) – Giving paracetamol (acetaminophen) to patients ill with severe malaria made them less likely to develop potentially fatal kidney failure, say researchers in a recent study in Clinical Infectious Diseases.
Professor Kevin Baird, Head of EOCRU in Jakarta, Indonesia, talks about how more needs to be done to mitigate the threat of malaria in Asia Pacific. This article includes photos from Pearl Gan who travelled through the Asia Pacific region to capture the stories of people and communities impacted by malaria.
Together with Evidence Aid, Professor Jay Berkley from KWTRP is launching a process to get research into practice in humanitarian emergencies. Systematic reviews and teleconference meetings to discuss how clinical trials can inform programmes and practice are published online, with an editorial highlighting the issues and need for policies to be based on research evidence.
FIEBRE aims to design new evidence-based guidelines to manage fever, thereby ensuring that patients get drugs that give them the best chance of recovery, and thereby help stop the spread of antimicrobial resistance (AMR), a major global health problem.
ERGO is launching ALERRT, a multi-disciplinary consortium building a patient-centered clinical research network to respond to epidemics across sub-Saharan Africa. ALERRT aims to reduce the public health and socio-economic impact of disease outbreaks in sub-Saharan Africa by building a sustainable clinical and laboratory research preparedness and response network.
In collaboration with Cambodian authorities, MORU are running the Village Drama Against Malaria project for the third year. The project, which runs in 10 remote villages in March 2018, aims to create awareness about malaria prevention and early treatment.
Research led by Dr Marco Haenssgen has revealed how the complex cultural and social environment in developing countries can complicate the use of new diagnostic technologies to fight the global superbug crisis.